Primaquine Phosphate
Product Images NDC 33261-671

3 FDA label images from Aidarex Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Primaquine Phosphate (NDC 33261-671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 76385-102-01 Primaquine Phosphate Tablets, Usp 26.3 mg (=15 mg Base) (Primaquine Po4 26 3mg 1)

Ndc 76385-102-01 Primaquine Phosphate Tablets, Usp 26.3 mg (=15 mg Base) (Primaquine Po4 26 3mg 1)
Primaquine Phosphate USP label by Aidarex Pharmaceuticals shows 26.3 mg strength in 14 film-coated tablets per bottle. The label includes the NDC 33261-0671-14 and notes each tablet contains 26.3 mg primaquine phosphate (15 mg base). It states the tablets are purple, round with a '4' on one side. The manufacturer is BayShore Pharmaceuticals, LLC, Short Hills, NJ.*
FDA Label Image

Primaquine 26.3mg Tabs #28 (Primaquine Po4 26 3mg 2)

Primaquine 26.3mg Tabs #28 (Primaquine Po4 26 3mg 2)
Label for Primaquine Phosphate USP tablets by Aidarex Pharmaceuticals LLC. Each tablet contains 26.3 mg of Primaquine Phosphate. The label indicates a package of 28 tablets and includes prescription information fields for doctor, date, and patient. The tablets are described as purple round with four on one side. Manufactured for Bayshore Pharmaceuticals, LLC.*
FDA Label Image

Primaquine 26.3mg Tabs (Primaquine Po4 26 3mg 3)

Primaquine 26.3mg Tabs (Primaquine Po4 26 3mg 3)
Primaquine Phosphate, USP 26.3 mg film-coated tablets in a 100-tablet package. The label indicates the product is from Aidarex Pharmaceuticals LLC, with manufacturing by Bayshore Pharmaceuticals LLC, Short Hills, NJ. The tablet is described as purple and round with four markings on one side. The label includes typical prescription fields for doctor, patient, dosage, and directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.